Immune Cell Assays
Our philosophy is to comprehensively understand a molecule’s mechanisms of action and risk profile, as early as possible in the drug development process, to minimise the chance of unanticipated issues arising in the clinical phases.
We create in vitro models that mimic disease biology as closely as possible, to allow therapeutic candidates to be tested in a context that yields meaningful data and from which decisions can be reliably taken.
Our models are designed to yield information more reflective of the true MOAs (Mechanism Of Action) and can highlight potential safety concerns early. Our approach to enhanced in vitro characterisation is in alignment with initiatives to reduce the burden of in vivo testing requirements and provide safer and more cost-effective approaches.
Drawing on our immunology expertise, we have built an array of systems that recapitulate key immune cell functions and interactions in both health and disease. With a strong focus on novel and emerging therapeutic classes that are designed to modulate these processes, our assay platforms are applicable to oncology, auto-immunity and beyond. By constantly expanding our knowledge base and capabilities, we provide you with a comprehensive and cutting-edge suite of solutions that evolve alongside your changing needs.
Immune cell types
Learn more about the in vitro models and co-culture formats we can apply to interrogate the effect of your drug on various immune cell types and their interplay with target cells. Each of these models can be harnessed and readily adapted to suit the in vitro testing of your drug candidates. Explore our immune cell assays by cell type:
Backed by brilliant minds
Our considerable knowledge will guide you through your journey.
EXPLORE OUR SCIENTIFIC RESOURCES